Vilsboll T, Bain SC, Leiter LA, Lingvay I, Matthews D, Simo R, Helmark IC, Wijayasinghe N, Larsen M
In an embryofetal development study in pregnant cynomolgus monkeys, subcutaneous doses of 0.015, 0.075 and 0.15 mg/kg twice weekly (1.9-, 9.9- and 29-fold the MRHD) were administered throughout organogenesis, from Gestation Day 16 to 50
But the vial does not say whether it contains CJC-1295 with DAC or without DAC, and that distinction changes everything about how you dose it
By leveraging translational insights from these data, we consider potential implications for clinical practice and propose avenues for further research
This indicates an approximate 20 fold increased affinity of the GST-GFP to 5:1 PEGDA:GSH compared to PEGDA
But its also the stage that requires the most careful investigation, because removing the wrong things or missing the real triggers entirely means the subsequent steps are building on an unstable foundation